These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7716955)

  • 21. [Lack of tolerance development in interval therapy with 50 mg isosorbide-5-nitrate retard (Elantan long)].
    Jansen W; Prenzel R; Kümper H; Weidmann B; Tauchert M
    Z Kardiol; 1989; 78 Suppl 2():72-8; discussion 115-7. PubMed ID: 2511697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of nitrates on red blood cell deformability and clinical parameters in patients with silent ischemia].
    Dłuzniewski M; Lada W; Mamcarz A; Raczkowska A; Król J; Podogrodzka B; Jurgiel R; Swiatowiec A; Sitkiewicz W; Pawińska M; Janas J; Kuch J
    Pol Merkur Lekarski; 1997 Jan; 2(9):179-83. PubMed ID: 10907022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The association of amlodipine with isosorbide-5-mononitrate in the treatment of ischemic-hypertensive cardiopathy].
    Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Kristodhullo A
    Clin Ter; 1992 Jul; 141(7):9-14. PubMed ID: 1387055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rationale for nitrates in angina pectoris.
    Held P; Olsson G
    Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endothelial dysfunction in patients with chronic heart failure, and possibilities of its correction with isosorbide-5-mononitrates].
    Ol'binskaia LI; Sizova ZhM; Kolbaia NG
    Klin Med (Mosk); 2007; 85(1):27-31. PubMed ID: 17419351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
    Schuster P; Trieb G; Wiechmann HW
    Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Left ventricular function parameters following administration of isosorbide-5-mononitrate].
    Bergbauer M
    Med Welt; 1983 Jun; 34(22):642-4. PubMed ID: 6877071
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
    G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effect of nitrates (Olicard 40) and their influence on deforming of erythrocytes against the background of 24-hour catecholaminuria].
    Dłuźniewski M; Lada W; Raczkowska A; Mamcarz A; Podogrodzka B; Swiatowiec A; Jurgiel R; Sitkiewicz W; Pawińska M
    Wiad Lek; 1994 Sep; 47(17-18):641-8. PubMed ID: 7571611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New drug forms of isosorbide dinitrate: the problem of an objective evaluation in patients with ischemic heart disease].
    Martsevich SIu; Metelitsa VI; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Piotrovskiĭ VK
    Farmakol Toksikol; 1991; 54(3):53-6. PubMed ID: 1915825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
    Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
    Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
    Wiechmann HW; Schuster P; Trieb G
    Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
    Straka RJ; Fish JT; Benson SR; Suh JT
    Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
    Fazzini PF; Pucci P
    Cardiologia; 1987 Nov; 32(11):1297-302. PubMed ID: 3447703
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
    Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
    Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
    Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
    Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.